TP53 and myelodysplastic syndrome: A comprehensive collection of cytogenetic data (G-banding analysis) and sequencing data (genome-wide copy number probes and capture-based NGS) were employed to resolve the clinical implications of TP53 mutations and their allelic status in MDS.